Adam Schayowitz

513 total citations
10 papers, 394 citations indexed

About

Adam Schayowitz is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Adam Schayowitz has authored 10 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Oncology. Recurrent topics in Adam Schayowitz's work include Estrogen and related hormone effects (6 papers), HER2/EGFR in Cancer Research (3 papers) and Prostate Cancer Treatment and Research (3 papers). Adam Schayowitz is often cited by papers focused on Estrogen and related hormone effects (6 papers), HER2/EGFR in Cancer Research (3 papers) and Prostate Cancer Treatment and Research (3 papers). Adam Schayowitz collaborates with scholars based in United States. Adam Schayowitz's co-authors include Angela Brodie, Gauri Sabnis, Vincent C.O. Njar, Luciana F. Macedo, Olga Goloubeva, Olga Goloubeva, Aashvini Belosay, Tadas S. Vasaitis, Lalji K. Gediya and Hong‐Bin Fang and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Adam Schayowitz

10 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Schayowitz United States 8 203 184 165 139 95 10 394
Jinpei Kumagai Japan 11 176 0.9× 126 0.7× 249 1.5× 87 0.6× 68 0.7× 14 437
Avery Spitz United States 4 380 1.9× 54 0.3× 180 1.1× 151 1.1× 155 1.6× 12 484
Myles C. Hodgson United States 11 214 1.1× 132 0.7× 357 2.2× 88 0.6× 73 0.8× 14 565
Andrew K. Kwegyir‐Afful United States 10 186 0.9× 84 0.5× 247 1.5× 51 0.4× 65 0.7× 12 392
Sonal J. Desai United States 8 210 1.0× 69 0.4× 186 1.1× 155 1.1× 32 0.3× 10 424
Carol M. Dutkowski United Kingdom 9 87 0.4× 188 1.0× 329 2.0× 287 2.1× 35 0.4× 14 544
Amanda Beyer United States 12 193 1.0× 311 1.7× 317 1.9× 314 2.3× 38 0.4× 17 661
J M Knowlden United Kingdom 6 120 0.6× 127 0.7× 311 1.9× 367 2.6× 94 1.0× 6 574
Oliver Sartor United States 10 346 1.7× 58 0.3× 97 0.6× 90 0.6× 120 1.3× 22 437
Shivang Doshi United States 4 406 2.0× 156 0.8× 184 1.1× 80 0.6× 117 1.2× 5 528

Countries citing papers authored by Adam Schayowitz

Since Specialization
Citations

This map shows the geographic impact of Adam Schayowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Schayowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Schayowitz more than expected).

Fields of papers citing papers by Adam Schayowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Schayowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Schayowitz. The network helps show where Adam Schayowitz may publish in the future.

Co-authorship network of co-authors of Adam Schayowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Schayowitz. A scholar is included among the top collaborators of Adam Schayowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Schayowitz. Adam Schayowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ball, Douglas W., Ning Jin, Ping Xue, et al.. (2015). Trametinib with and without pazopanib has potent preclinical activity in thyroid cancer. Oncology Reports. 34(5). 2319–2324. 19 indexed citations
2.
Schayowitz, Adam, Greg P. Bertenshaw, Jessie Villanueva, et al.. (2012). Functional Profiling of Live Melanoma Samples Using a Novel Automated Platform. PLoS ONE. 7(12). e52760–e52760. 7 indexed citations
3.
Schayowitz, Adam, Gauri Sabnis, Olga Goloubeva, Vincent C.O. Njar, & A. Brodie. (2010). Prolonging hormone sensitivity in prostate cancer xenografts through dual inhibition of AR and mTOR. British Journal of Cancer. 103(7). 1001–1007. 26 indexed citations
4.
Sabnis, Gauri, Adam Schayowitz, Olga Goloubeva, Luciana F. Macedo, & Angela Brodie. (2009). Trastuzumab Reverses Letrozole Resistance and Amplifies the Sensitivity of Breast Cancer Cells to Estrogen. Cancer Research. 69(4). 1416–1428. 85 indexed citations
5.
Sabnis, Gauri, Luciana F. Macedo, Olga Goloubeva, Adam Schayowitz, & Angela Brodie. (2008). Stopping Treatment Can Reverse Acquired Resistance to Letrozole. Cancer Research. 68(12). 4518–4524. 43 indexed citations
6.
Vasaitis, Tadas S., Aashvini Belosay, Adam Schayowitz, et al.. (2008). Androgen receptor inactivation contributes to antitumor efficacy of 17α-hydroxylase/17,20-lyase inhibitor 3β-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer. Molecular Cancer Therapeutics. 7(8). 2348–2357. 111 indexed citations
7.
Schayowitz, Adam, Gauri Sabnis, Vincent C.O. Njar, & Angela Brodie. (2008). Synergistic effect of a novel antiandrogen, VN/124-1, and signal transduction inhibitors in prostate cancer progression to hormone independence in vitro. Molecular Cancer Therapeutics. 7(1). 121–132. 48 indexed citations
8.
Sabnis, Gauri, Luciana F. Macedo, Olga Goloubeva, et al.. (2007). Toremifene–atamestane; alone or in combination: Predictions from the preclinical intratumoral aromatase model. The Journal of Steroid Biochemistry and Molecular Biology. 108(1-2). 1–7. 6 indexed citations
9.
Sabnis, Gauri, Olga Goloubeva, Danijela Jelovac, Adam Schayowitz, & Angela Brodie. (2007). Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway Improves Response of Long-term Estrogen-Deprived Breast Cancer Xenografts to Antiestrogens. Clinical Cancer Research. 13(9). 2751–2757. 45 indexed citations
10.
Sabnis, Gauri, Danijela Jelovac, Brian J. Long, et al.. (2006). Mammalian target of rapamycin (mTOR) as a target in human breast cancer cells that have acquired resistance to aromatase inhibitor letrozole. Cancer Research. 66. 547–547. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinpei Kumagai Breakdown of academic impact, for papers by Avery Spitz Breakdown of academic impact, for papers by Myles C. Hodgson Breakdown of academic impact, for papers by Andrew K. Kwegyir‐Afful Breakdown of academic impact, for papers by Sonal J. Desai Breakdown of academic impact, for papers by Carol M. Dutkowski Breakdown of academic impact, for papers by Amanda Beyer Breakdown of academic impact, for papers by J M Knowlden Breakdown of academic impact, for papers by Oliver Sartor Breakdown of academic impact, for papers by Shivang Doshi
Rankless by CCL
2026